第一单位:
Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.;Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
作者:
Srijit,Seal [1]
;
Manas,Mahale [2]
;
Miguel,García-Ortegón [3]
;
Chaitanya K,Joshi [4]
;
Layla,Hosseini-Gerami [5]
;
Alex,Beatson [6]
;
Matthew,Greenig [3]
;
Mrinal,Shekhar [7]
;
Arijit,Patra [8]
;
Caroline,Weis [9]
;
Arash,Mehrjou [9]
;
Adrien,Badré [10]
;
Brianna,Paisley [11]
;
Rhiannon,Lowe [12]
;
Shantanu,Singh [7]
;
Falgun,Shah [13]
;
Bjarki,Johannesson [14]
;
Dominic,Williams [14]
;
David,Rouquie [15]
;
Djork-Arné,Clevert [16]
;
Patrick,Schwab [9]
;
Nicola,Richmond [17]
;
Christos A,Nicolaou [18]
;
Raymond J,Gonzalez [13]
;
Russell,Naven [10]
;
Carolin,Schramm [19]
;
Lewis R,Vidler [20]
;
Kamel,Mansouri [21]
;
W Patrick,Walters [22]
;
Deidre Dalmas,Wilk [23]
;
Ola,Spjuth [24]
;
Anne E,Carpenter [7]
;
Andreas,Bender [25]
作者单位:
Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.;Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
[1]
Department of Pharmaceutical Chemistry, Bombay College of Pharmacy, Mumbai 400098, India.
[2]
Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
[3]
Department of Computer Science and Technology, University of Cambridge, Cambridge CB3 0FD, U.K.
[4]
IgnotaLabs, Cambridge CB4 0GA, U.K.
[5]
Axiom Bio, San Francisco, California 94107, United States.
[6]
Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
[7]
UCB Pharma U.K., Slough SL1 3WE, U.K.
[8]
GSK, London WC1A 1DG, U.K.
[9]
Novartis Biomedical Research, Cambridge, Massachusetts 02139, United States.
[10]
Eli Lilly & Company, Indianapolis, Indiana 46285, United States.
[11]
Relation Therapeutics, London NW1 3BG, U.K.
[12]
Non Clinical Drug Safety, Merck Inc., West Point, Pennsylvania 19486, United States.
[13]
AstraZeneca, Pepparedsleden 1 43183 Molndal, Sweden.
[14]
Toxicology Data Science, Bayer SAS Crop Science Division, Valbonne Sophia-Antipolis 06560, France.
[15]
Pfizer, Worldwide Research, Development and Medical, Machine Learning & Computational Sciences, Berlin 10922, Germany.
[16]
Recursion, London N1C 4AG, U.K.
[17]
Computational Drug Design, Digital Science & Innovation, Novo Nordisk US R&D, Lexington, Massachusetts 02421, United States.
[18]
Sanofi, Babraham Research Campus, Cambridge CB22 3AT, U.K.
[19]
Eli Lilly and Company, Bracknell RG12 1PU, U.K.
[20]
NIH/NIEHS/DTT/NICEATM, Research Triangle Park, North Carolina 27709, United States.
[21]
Relay Therapeutics, Cambridge, Massachusetts 02141, United States.
[22]
Nonclinical Safety, Collegeville Pennsylvania 19426, United States.
[23]
Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala 751 24, Sweden.;Phenaros Pharmaceuticals AB, Uppsala 75239, Sweden.
[24]
Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.;College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates.
[25]
DOI
10.1021/acs.chemrestox.5c00033
PMID
40314361
发布时间
2025-05-23